- 詳細內容
- 發佈：2020-02-27
 |
Dr. Wang, Kai-Hung | |
| E-mail:kennyhug0201@gmail.com | ||
| Ext：15614 | ||
| Tzu Chi University, Taiwan. Ph.D. |
||
|
Expertise： Molecular biology and immuno-oncology.
|
Experence：
Institute of Biotechnology and Pharmaceutical Research, NHRI. Postdoctoral fellow
Interest：
Tumor biology
Immuno-oncology
Cell therapy
Publication (in five years)：：
|
1. |
Wang KH, Chu SC, Chu TY. Loss of calponin h1 confers anoikis resistance and tumor progression in the development of high-grade serous carcinoma originating from the fallopian tube epithelium. Oncotarget. 2017 May 19. |
|
2. |
Wang KH, Lin CJ, Liu CJ, Liu DW, Huang RL, Ding DC, Weng CF, Chu TY. Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV. Cancer Med. 2015 Jan;4(1):43-55. |
